Is Pea Protein Muscle Strength Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Pea Protein Muscle Strength Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - According to the internationally used definition, MetS is characterized by having at least three out of several possible risk factors, including high blood pressure, hypertriglyceridemia, low levels of HDL cholesterol, elevated fasting glucose, and central obesity (). [Wang Song-nan (2026); evidence level 3] - α p p 6 7 9 9 10 6 High levels of TNF-, IL-6, and CRP are associated with insulin resistance, endothelial dysfunction, and atherogenesis (,,). [Wang Song-nan (2026); evidence level 3] - Such increases appear to be closely linked to MetS, type 2T2DM, and CVD risk (,). [Wang Song-nan (2026); evidence level 3] - 1 1 The metabolic syndrome (MetS), one of the most significant public health problems of the 21st century, is characterized by central obesity, insulin resistance, hypertension, and dyslipidemia. [Wang Song-nan (2026); evidence level 3] - Large prospective cohort studies consistently report that higher intakes of plant-based proteins are associated with lower cardiovascular and all-cause mortality, whereas higher consumption of certain animal-based protein sources—particularly processed red meat—is linked to adverse health outcomes [,,,,,]. [Cannito Teresa (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.